Differences in antigenic structure of inactivated poliovaccines made from Sabin live-attenuated and wild-type poliovirus strains: impact on vaccine potency assays.
Crawt, Laura; Atkinson, Eleanor; Tedcastle, Alison; Pegg, Elaine; Minor, Philip; Cooper, Gillian; Rigsby, Peter; Martin, Javier.
J Infect Dis
; 2019 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-30788503
Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018.
Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.
Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.
A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus.
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use.
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game.
Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 - Worldwide, 2016-2017.